Qingieng Zeng

Title: The Innovative Contributions of Qingieng Zeng

Introduction

Qingieng Zeng is a notable inventor based in Ballwin, MO (US). He has made significant contributions to the field of biomedical research, particularly in the development of anticoagulant therapies. His work focuses on innovative compounds that can effectively inhibit the coagulation cascade, which is crucial for treating various thrombotic conditions.

Latest Patents

Qingieng Zeng holds a patent for "Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade." This invention relates to substituted polycyclic aryl and heteroaryl pyridone compounds that serve as inhibitors of serine proteases involved in the coagulation cascade. The compounds, compositions, and methods developed by Zeng are aimed at providing effective anticoagulant therapy for the treatment and prevention of thrombotic conditions, including coronary artery and cerebrovascular diseases. He has 1 patent to his name.

Career Highlights

Zeng is associated with Pharmacia Corporation, where he has been able to apply his innovative ideas in a practical setting. His work at the company has allowed him to contribute to advancements in medical therapies that can improve patient outcomes.

Collaborations

Throughout his career, Qingieng Zeng has collaborated with notable colleagues, including Michael S South and Melvin L Rueppel. These collaborations have likely enhanced the scope and impact of his research.

Conclusion

Qingieng Zeng's contributions to the field of biomedical research through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in anticoagulant therapies, ultimately benefiting patients with thrombotic conditions.